Glaspy J, Smith R, Aapro M, et al. Results from a Phase III, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in patients not receiving chemotherapy or radiotherapy. AACR Annual Meeting; 2007; Los Angeles, CA; 2007.
Google Scholar
Goldberg P. Danish researchers post long-awaited Aranesp results - ever so discretely. Cancer Lett 2007;33:1
Google Scholar
Henke M, Laszig R, Rube C,. et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-6
PubMed Web of Science ®Google Scholar
Leyland-Jones B, Semiglazov V, Pawlicki M,. et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005;23:5960-72
PubMed Web of Science ®Google Scholar
Wright JR, Ung YC, Julian JA,. et al. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007; 25:1027-32
PubMed Web of Science ®Google Scholar
Oncologic Drugs Advisory Committee Meeting. http://wwwfdagov/ohrms/dockets/ac/07/slides/2007-4301s2-00-indexhtm 2007 [cited 2007 December 08]
Google Scholar
Bohlius J, Wilson J, Seidenfeld J, et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane database of systematic reviews (Online) 2006;3: CD003407
Google Scholar
Bohlius J, Wilson J, Seidenfeld J,. et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 2006; 98:708-14
PubMed Web of Science ®Google Scholar
Erythropoetin: Ergebnisse klinischer Studien an onkologischen Patienten mit oder ohne Anämie. http://wwwbfarmde/nn_424276/DE/Pharmakovigilanz/risikoinfo/erythropoetinhtml __nnn=true 2007 16.8.2007 [cited 2007 December, 8]; Available from: http://www.bfarm.de/nn_424276/DE/Pharmakovigilanz/risikoinfo/erythropoetin.html__nnn=true
Google Scholar
European Medicines Agency starts review of the safety of epoetins. http://wwwemeaeuropaeu/pdfs/human/press/pus/18806807enpdf 2007 16.08.2007 [cited 2008 December, 8]; Available from: http://www.emea.europa.eu/pdfs/human/press/pus/18806807en.pdf
Google Scholar
Corwin HL, Gettinger A, Fabian TC,. et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007; 357:965-76
PubMed Web of Science ®Google Scholar
Bokemeyer C, Aapro MS, Courdi A,. et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258-70
PubMed Web of Science ®Google Scholar
Khuri FR. Weighing the hazards of erythropoiesis stimulation in patients with cancer. N Engl J Med 2007;356:2445-8
PubMed Web of Science ®Google Scholar
Lappin TR, Maxwell AP, Johnston PG. Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia. Oncologist 2007;12:362-5
PubMed Web of Science ®Google Scholar
Rizzo JD, Lichtin AE, Woolf SH,. et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002; 20: 4083-107
PubMed Web of Science ®Google Scholar
Rizzo JD, Lichtin AE, Woolf SH,. et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 2002;100:2303-20
PubMed Web of Science ®Google Scholar
Steinmetz T, Hellmich M, Neise M,. et al. Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumors. The oncologist 2007;12:748-55
PubMed Web of Science ®Google Scholar
Ludwig H. Anemia of hematologic malignancies: what are the treatment options? Semin Oncol 2002;29:45-54
PubMed Web of Science ®Google Scholar
Barrett-Lee P, Bokemeyer C, Gascon P,. et al. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Oncologist 2005; 10: 743-57
PubMed Web of Science ®Google Scholar
Birgegard G, Gascon P, Ludwig H. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European Cancer Anaemia Survey. Eur J Haematol 2006 Nov;77 (5):378-86
PubMed Web of Science ®Google Scholar
Engelhardt M, Thierry V, Aulitzky W. Behandlung mit hämatopoetischen Wachstumsfaktoren (HGF). http://wwwdghode/_cmsdata/_file/file_137pdf
Google Scholar
Bundesärztekammer WBd. Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Deutsches Ärzteblatt. 2002 6. December 2002;99(49)
Google Scholar
Hess G, Hill J, Clough J,. et al. Utilization of darbepoetin alfa in relation to cancer patients’ hemoglobin levels. Curr Med Res Opin 2008;24:815-19
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia – examination of practice in Germany

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature